In last trading session, Bicara Therapeutics Inc (NASDAQ:BCAX) saw 0.56 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $14.38 trading at -$0.87 or -5.70% at ring of the bell on the day assigns it a market valuation of $782.50M. That closing price of BCAX’s stock is at a discount of -95.34% from its 52-week high price of $28.09 and is indicating a discount of -5.35% from its 52-week low price of $15.15. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 428.63K if we extend that period to 3-months.
Bicara Therapeutics Inc (NASDAQ:BCAX) trade information
Upright in the red during last session for losing -5.70%, in the last five days BCAX remained trading in the red while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $14.38 price level, adding 17.31% to its value on the day. Bicara Therapeutics Inc’s shares saw a change of -17.45% in year-to-date performance and have moved -15.04% in past 5-day. Bicara Therapeutics Inc (NASDAQ:BCAX) showed a performance of -31.98% in past 30-days. Number of shares sold short was 3.03 million shares which calculate 8.84 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 35 to the stock, which implies a rise of 58.91% to its current value. Analysts have been projecting 35 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -143.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -143.39% for stock’s current value.
On the other hand, Price (T.Rowe) New Horizons Fund and AB Cap Fd.-AB Small Cap Growth Port are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 589.53 shares of worth $8.48 million or 1.08% of the total outstanding shares. The later fund manager was in possession of 410.71 shares on Nov 30, 2024 , making its stake of worth around $5.91 million in the company or a holder of 0.75% of company’s stock.